We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Spread of Transversus Abdominis Plane Block

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01024868
First Posted: December 3, 2009
Last Update Posted: May 4, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Glostrup University Hospital, Copenhagen
Information provided by:
Herlev Hospital
December 2, 2009
December 3, 2009
May 4, 2010
December 2009
March 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01024868 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessment of Spread of Transversus Abdominis Plane Block
Assessment of Spread of Transversus Abdominis Plane Block After Administration of 20 ml Ropivacaine 0,5% Bilaterally
For the purpose of assessing the spread of the local anaesthetic after injecting it between abdominal muscles on both sides, the investigators will test if the patient can feel a change in the perception of cold and warm, as well as being pricked with a blunt needle. The investigators will also take several blood samples, together with routine samples, to measure the concentration of the local anesthetic in the blood.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients undergoing abdominal surgery
Transversus Abdominis Plane Block
Drug: Ropivacaine 0,5%
Injection of ropivacaine 0,5% 20 ml bilaterally before surgery
TAP block
Patients before undergoing laparoscopic or other abdominal surgery
Intervention: Drug: Ropivacaine 0,5%

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
Not Provided
March 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • undergo abdominal surgery, eligible for TAP block, over 18, BMI 20-40

Exclusion Criteria:

  • does not speak danish, does not consent, does not fulfill inclusion criteria
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT01024868
TDTSG-1
No
Not Provided
Not Provided
Dr Anja U. Mitchell, Herlev University Hospital, Copenhagen
Herlev Hospital
Glostrup University Hospital, Copenhagen
Study Director: Ann M Møller, dr. med. Herlev Hospital
Herlev Hospital
December 2009